Literature DB >> 31102067

The value of virtual touch tissue imaging quantification in the differential diagnosis between benign and malignant breast lesions.

Wen-Tao Kong1, Wei-Jun Zhou1, Yin Wang1, Xiao-Min Zhuang2, Min Wu3.   

Abstract

PURPOSE: To evaluate the value and diagnostic performance of virtual touch tissue imaging quantification (VTIQ) and to determine the optimum cut-off value for differential diagnosis between benign and malignant breast lesions.
METHODS: Conventional ultrasonography (US) and VTIQ were performed in 454 patients with 466 breast lesions with a Siemens Acuson S3000 ultrasound machine. All lesions were assessed by an ultrasound Breast Imaging Reporting and Data System (BI-RADS) and confirmed by histopathology. The maximum, mean, and minimum shear wave velocity (SWV) values were quantitatively measured in m/s within the regions of interest (ROIs) and ranged from 0.5 to 10 m/s. The sensitivity, specificity, accuracy, and area under the receiver operating curve (AUC) of the VTIQ, BI-RADS, and combined data were compared.
RESULTS: Among the 466 breast lesions, 266 were benign and 200 were malignant. All of the SWV values of the malignant lesions were significantly greater than those of the benign ones (P < 0.05). The optimal cut-off values for SWVmax, SWVmin, SWVmean, and SWVmax/SWVmin obtained from ROC analysis were 5.37 m/s, 3.08 m/s, 4.04 m/s, and 1.83, respectively. Logistic regression analysis revealed that BI-RADS was an independent risk factor for the differential diagnosis of breast lesions, whereas SWV values were not independent risk factors.
CONCLUSIONS: VTIQ is useful in the differential diagnosis between benign and malignant breast lesions. The combination of VTIQ and ultrasonic BI-RADS can improve the diagnostic performance.

Entities:  

Keywords:  Breast imaging reporting and data system; Diagnostic performance; Shear wave velocity; Virtual touch tissue imaging quantification

Mesh:

Year:  2019        PMID: 31102067     DOI: 10.1007/s10396-019-00948-0

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  17 in total

1.  Virtual touch tissue quantification using acoustic radiation force impulse technology: initial clinical experience with solid breast masses.

Authors:  Min Bai; Lianfang Du; Jiying Gu; Fan Li; Xiao Jia
Journal:  J Ultrasound Med       Date:  2012-02       Impact factor: 2.153

2.  Combination of two-dimensional shear wave elastography with ultrasound breast imaging reporting and data system in the diagnosis of breast lesions: a new method to increase the diagnostic performance.

Authors:  Dan-Dan Li; Hui-Xiong Xu; Le-Hang Guo; Xiao-Wan Bo; Xiao-Long Li; Rong Wu; Jun-Mei Xu; Yi-Feng Zhang; Kun Zhang
Journal:  Eur Radiol       Date:  2015-12-29       Impact factor: 5.315

3.  Added value of Virtual Touch IQ shear wave elastography in the ultrasound assessment of breast lesions.

Authors:  Victor Ianculescu; Laura Maria Ciolovan; Ariane Dunant; Philippe Vielh; Chafika Mazouni; Suzette Delaloge; Clarisse Dromain; Alexandru Blidaru; Corinne Balleyguier
Journal:  Eur J Radiol       Date:  2014-02-06       Impact factor: 3.528

4.  Relationship between parameters from virtual touch tissue quantification (VTQ) imaging with clinicopathologic prognostic factors in women with invasive ductal breast cancer.

Authors:  Juan Xie; Rong Wu; Hui-Xiong Xu; Ming-Hua Yao; Guang Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 5.  Acoustic radiation force impulse elastography for differentiation of malignant and benign breast lesions: a meta-analysis.

Authors:  Dan-Dan Li; Le-Hang Guo; Hui-Xiong Xu; Chang Liu; Jun-Mei Xu; Li-Ping Sun; Jian Wu; Bo-Ji Liu; Lin-Na Liu; Xiao-Hong Xu
Journal:  Int J Clin Exp Med       Date:  2015-04-15

6.  Value of Virtual Touch Tissue Imaging Quantification for Evaluation of Ultrasound Breast Imaging-Reporting and Data System Category 4 Lesions.

Authors:  Xiao-Long Li; Hui-Xiong Xu; Xiao-Wan Bo; Bo-Ji Liu; Xian Huang; Dan-Dan Li; Le-Hang Guo; Jun-Mei Xu; Li-Ping Sun; Lin Fang; Xiao-Hong Xu
Journal:  Ultrasound Med Biol       Date:  2016-05-09       Impact factor: 2.998

7.  Shear wave velocity measurements for differential diagnosis of solid breast masses: a comparison between virtual touch quantification and virtual touch IQ.

Authors:  Mitsuhiro Tozaki; Masahiro Saito; John Benson; Liexiang Fan; Sachiko Isobe
Journal:  Ultrasound Med Biol       Date:  2013-09-21       Impact factor: 2.998

8.  Shear-wave elastography and greyscale assessment of palpable probably benign masses: is biopsy always required?

Authors:  Elisabetta Giannotti; Sarah Vinnicombe; Kim Thomson; Dennis McLean; Colin Purdie; Lee Jordan; Andy Evans
Journal:  Br J Radiol       Date:  2016-03-23       Impact factor: 3.039

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

10.  Diagnostic value of elastography using acoustic radiation force impulse imaging and strain ratio for breast tumors.

Authors:  Yoon Seok Kim; Jung Gu Park; Beom Su Kim; Chung Han Lee; Dong Won Ryu
Journal:  J Breast Cancer       Date:  2014-03-28       Impact factor: 3.588

View more
  2 in total

1.  Qualitative Evaluation of Virtual Touch Imaging Quantification: A Simple and Useful Method in the Diagnosis of Breast Lesions.

Authors:  Ying Zhu; Xiao-Hong Jia; Wei Zhou; Wei-Wei Zhan; Jian-Qiao Zhou
Journal:  Cancer Manag Res       Date:  2020-03-18       Impact factor: 3.989

2.  The value of automated breast volume scanner combined with virtual touch tissue quantification in the differential diagnosis of benign and malignant breast lesions: A comparative study with mammography.

Authors:  Junli Wang; Hongjie Fan; Yuting Zhu; Chunyun Shen; Banghong Qiang
Journal:  Medicine (Baltimore)       Date:  2021-04-23       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.